
Antiphospholipid syndrome (APS) is a serious autoimmune condition that mainly affects women of childbearing age (WoCBA) and can cause serious adverse pregnancy outcomes, with no therapies currently approved. The Breakthrough Therapy Designation (BTD) is supported by findings from the...
Pr Newswire
Original source
ucb bd
Check live status on DownRightNow



